April 17, 2017
Verily has debuted a new health-tracking wearable designed for use in a series of observational and longitudinal studies. With the aptly dubbed Study Watch – which is not available for consumer purchase – the Alphabet subsidiary formerly known as Google Life Sciences aims to push new boundaries in the size, scope and sophistication of wearable data-gathering.
Featuring numerous physiological and...
January 26, 2017
Verily, the Alphabet subsidiary formerly known as Google Life Sciences, raised $800 million in funding today from Temasek, a Singapore-based investment company. Temasek will take a minority stake in the company and nominate a member to the company's board.
“Temasek has a history of thoughtful and enduring capital investments, including in life sciences and healthcare, and this commitment to a...
January 18, 2017
A new kind of doctor’s office opened in San Francisco this week: Forward, a membership-based healthcare startup founded by former Googler Adrian Aoun that infuses a brick-and-mortar office with data-driven technology and artificial intelligence.
For $149 per month, Forward members can come to the flagship office that features six examination rooms – equipped with interactive personalized...
December 6, 2016
Bill Maris, the founder and former CEO of Google Ventures (later renamed GV) who left the company earlier this year, has reportedly raised $230 million for a new fund that will focus on healthcare investments.
As Recode reports, sources close to Maris said regulatory filings related to the funding will be released as early as this week. The fund is called Section 32, and will largely be run by...
September 12, 2016
Verily Life Sciences, a division of Google parent company Alphabet, has teamed up with French healthcare company Sanofi to launch Onduo, a diabetes-focused collaboration that leverages Sanofi’s pharmaceutical expertise and Verily’s command of miniaturized electronics, analytics and consumer software development. The two companies together invested about $500 million in Onduo.
The joint venture is...
February 25, 2016
Google DeepMind, a UK-based artificial intelligence subsidiary of Google, has entered the healthcare space with a new partnership with the UK's National Health Service. Google acquired the UK-based DeepMind in January 2014. While DeepMind is known for AI, the partnership so far is built around two apps that don't use AI at all.
"[A]rtificial intelligence is not part of the early-stage pilots we’...
January 11, 2016
Google has filed another interesting healthcare-related patent, a mechanism that could detect when a patient is eating and issue a contextual reminder to take a medication.
Israel-based patent authors Asaf Zomet and Michael Shynar describe the patented invention as one that uses some mechanism to detect when the user is eating, confirms that this is the case, and then delivers “a reminder to...
December 7, 2015
Google Life Sciences has finally gotten its new name as an independent company under the aegis of Alphabet: Verily. With the launch of a new website, the company has also clarified and cemented its mission: to bring different healthcare and technology stakeholders together to reinvent areas of healthcare.
"Imagine a chemist and an engineer and a doctor and a behavioral scientist, all working...
September 17, 2015
Google subsidiary Alphabet, has hired Dr. Tom Insel, former director of the National Institute of Mental Health (NIMH), to spearhead the company's mental health efforts in its life sciences division. Insel has worked as director of NIMH for 13 years before he moved to Google. In a statement about his transition, Insel said, "The GLS mission is about creating technology that can help with earlier...
September 8, 2015
Google and Novartis are working on two smart contact lenses, and news broke this week about both of them: A new patent application sheds light on how Google might power its glucose-sensing contact lens, just a week after partner Novartis told a Swiss newspaper it was on track for human trials in 2016 of an autofocus lens for presbyopia patients.
Patent applications don't always presage exactly...